Revenue
-
Net Income
-$115.9M
▼ 71.2% YoY
EPS
$-2.34
▼ 41.8% YoY
Cash
$164.0M
▼ 15.2% YoY
FY 2024 · As of 2024-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Chang David J. Chief Medical Officer | Buy | Jan 21, 2026 | 8.8K | $2.26 | $20K | Form 4 ↗ |
Binder Gwendolyn President, Science & Tech. | Buy | Jan 21, 2026 | 11.3K | $2.19 | $25K | Form 4 ↗ |
Tomasello Shawn Insider | Buy | Jan 21, 2026 | 22.7K | $2.21 | $50K | Form 4 ↗ |
Gavel Steve Chief Commercial Officer | Buy | Jan 21, 2026 | 22.2K | $2.27 | $50K | Form 4 ↗ |
Bollard Catherine Insider | Buy | Jan 21, 2026 | 4.4K | $2.27 | $10K | Form 4 ↗ |
Nichtberger Steven President & CEO | Buy | Jan 21, 2026 | 45.0K | $2.24 | $101K | Form 4 ↗ |